New Zealand-born, Illinois-based synthetic biology company LanzaTech NZ is destined for a Nasdaq listing after merging with a US company in a deal valuing the company at US$1.8 billion, announced this morning.
LanzaTech Global Inc, as it will be known, is expected to be the first carbon
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
